Position in TAK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,937,809
+$1,086,123 QoQ
Shares Held
158,629
+33.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 1.8685108019340726.ToString("F0")%
Shared 0.ToString("F0")%
None 98.13148919806592.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $56,556,259 across 24 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
216,286 | $25,567,168 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
11,253 | $6,672,803 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
37,584 | $4,951,316 | |
| 4 | HLN |
Haleon plc
|
371,702 | $3,720,737 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
158,629 | $2,937,809 | |
| 6 | VTRS |
Viatris Inc
|
199,616 | $2,696,812 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
40,252 | $2,080,625 | |
| 8 | HROW |
Harrow, Inc.
|
56,788 | $2,002,344 |
All Filings in TAK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,937,809 | 158,629 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,851,686 | 118,774 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $601,762 | 41,104 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $594,282 | 38,440 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $539,052 | 36,251 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $230,826 | 17,434 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $343,213 | 24,136 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $337,759 | 26,102 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $529,236 | 38,102 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $803,786 | 56,327 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $919,119 | 59,413 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $511,580 | 32,564 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $517,884 | 31,425 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $569,883 | 36,531 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $206,975 | 15,958 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $174,166 | 12,405 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $120,774 | 8,434 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $212,641 | 15,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $126,453 | 7,720 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $148,171 | 8,804 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $148,033 | 8,107 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $111,420 | 6,122 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $74,999 | 4,204 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $54,722 | 3,052 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||